Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
Copyright © 2021 Yeungnam University College of Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflict of interest
No potential conflict of interest relevant to this article was reported.
Funding
This study was supported by Inje University Haeundae Paik Hospital and a research grant from the Inje University in 2018 (No. 20180167).
Author contributions
Conceptualization: YWK; Writing-original draft: YJL; Writing-review & editing: YWK, BSP, SP, JHP, IHK, JK.
Variable | Acute kidney injury | Univariate logistic regression | Multivariate logistic regressiona) | ||||
---|---|---|---|---|---|---|---|
Yes (n=13) | No (n=338) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age (yr) | 67.92±13.49 | 66.34±11.03 | 0.280b) | 1.01 (0.96–1.07) | 0.614 | - | - |
Sex | |||||||
Male | 3 (23.1) | 79 (23.4) | >0.999c) | 0.98 (0.26–3.66) | 0.980 | - | - |
Female | 10 (76.9) | 259 (76.6) | - | - | |||
Diabetes mellitus | |||||||
Yes | 2 (15.4) | 66 (19.5) | >0.999c) | 0.75 (0.16–3.46) | 0.712 | - | - |
No | 11 (84.6) | 272 (80.5) | 1.00 | - | - | ||
Hypertension | |||||||
Yes | 11 (84.6) | 182 (53.8) | 0.029d) | 4.71 (1.03–21.59) | 0.046 | - | - |
No | 2 (15.4) | 156 (46.2) | 1.00 | - | - | ||
CKD | |||||||
Yes | 9 (69.2) | 57 (16.9) | <0.001c) | 11.09 (3.30–37.26) | <0.001 | - | - |
No | 4 (30.8) | 281 (83.1) | 1.00 | - | - | ||
ACEi | |||||||
Yes | 4 (30.8) | 110 (32.5) | >0.999c) | 0.88 (0.27–2.94) | 0.842 | - | - |
No | 9 (69.2) | 219 (64.8) | 1.00 | - | - | ||
NSAIDs | |||||||
Yes | 2 (15.4) | 50 (14.8) | >0.999c) | 1.01 (0.22–4.72) | 0.985 | - | - |
No | 11 (84.6) | 279 (82.5) | 1.00 | - | - | ||
Anesthesia | |||||||
Spinal | 11 (84.6) | 267 (79.0) | >0.999c) | 1.46 (0.32–6.75) | 0.626 | - | - |
General | 2 (15.4) | 71 (21.0) | 1.00 | - | - | ||
During operative bleeing (mL) | 155.77±149.41 | 227.57±260.51 | 0.558b) | 1.00 (1.00–1.00) | 0.325 | - | - |
Operation time (min) | 173.08±25.78 | 186.88±41.10 | 0.267b) | 0.99 (0.97–1.01) | 0.231 | - | - |
Type of surgery | |||||||
Total knee replacement | 9 (69.2) | 229 (67.8) | 1.000c) | 1.07 (0.32–3.55) | 0.911 | - | - |
Total hip replacement | 4 (30.8) | 109 (32.2) | 1.00 | - | - | ||
Preoperative GFR (mL/min/1.73 m2) | 66.66±34.02 | 78.07±21.23 | 0.043b) | 0.97 (0.95–1.00) | 0.058 | - | - |
ΔeGFR | –29.47±18.10 | 10.89±14.93 | <0.001e) | 0.82 (0.75–0.90) | <0.001 | 0.74 (0.61–0.89) | 0.002 |
Albumin (g/dL) | 3.31±0.32 | 3.67±0.42 | 0.001b) | 0.13 (0.03–0.49) | 0.003 | - | - |
Hemoglobin (g/dL) | 11.21±1.65 | 12.39±1.52 | 0.015b) | 0.61 (0.43–0.88) | 0.008 | 0.13 (0.02–0.68) | 0.016 |
Postopeative CRP (mg/L) | 13.73±8.09 | 13.39±7.18 | 0.786b) | 1.01 (0.93–1.09) | 0.870 | - | - |
Total CO2 (mmol/L) | 24.28±2.82 | 26.53±3.22 | 0.019b) | 0.78 (0.64–0.95) | 0.013 | - | - |
Ejection fraction (%) | 65.04±6.99 | 64.66±4.09 | 0.354b) | 1.02 (0.87–1.19) | 0.788 | - | - |
Hospital stay (day) | 24.82±6.59 | 23.55±12.14 | 0.104b) | 1.01 (0.96–1.06) | 0.731 | - | - |
No. of prescribed drug | 7.36±3.93 | 4.11±3.47 | 0.006b) | 1.23 (1.07–1.43) | 0.005 | - | - |
proBNP (ng/L) | 248.57±274.08 | 235.01±409.40 | 0.511b) | 1.00 (1.00–1.00) | 0.954 | - | - |
Fluid therapy | |||||||
Crystalloid | 8 (61.5) | 211 (62.4) | 1.000c) | 1.00 | - | - | |
Colloid | 5 (38.5) | 127 (37.6) | 1.04 (0.33–3.24) | 0.948 | - | - | |
Perioperative amount of fluid (mL) | 1,330.77±606.06 | 1,539.85±942.03 | 0.479b) | 1.00 (1.00–1.00) | 0.425 | - | - |
Values are presented as mean±standard deviation or number (%).
CKD, chronic kidney disease; ACEi, angiotensin-converting enzyme inhibitor; NSAIDs, nonsteroidal anti-inflammatory drugs; eGFR, estimated glomerular filtration rate; ΔeGFR, change in eGFR at postoperative from baseline; CRP, C-reactive protein; proBPN, pro-B-type natriuretic peptide.
a) In a multivariate logistic regression, the statistically significant variables in the univariate analyses were included. Then, categorical variables that have less frequency in a certain subgroup such as hypertension and CKD were excluded since the estimated odds ratio goes infinity and is not estimable. Finally, the statistically significant variables were selected in a backward elimination method with 0.05 alpha level.
The p-values were derived from b)Mann-Whitney U-test, c)Fisher exact test, d)chi-square test, and e)independent t-test. Shapiro-Wilk test was employed for test of normality assumption.
ΔeGFR, change in estimated glomerular filtration rate at postoperative from baseline; AUC, area under the curve; sensitivity, proportion of patients with acute kidney injury who had a lower than –7.54 for ΔeGFR; specificity, proportion of patients without acute kidney injury who had a higher than –7.54 for ΔeGFR; FNR, false-negative rate; FPR, false-positive rate; PPV, positive predicted value; NPV, negative predicted value.
Concordance between ΔeGFR with –7.54 and acute kidney injury was good (316/351, 90.03%).
Variable | Acute kidney injury | Univariate logistic regression | Multivariate logistic regression |
||||
---|---|---|---|---|---|---|---|
Yes (n=13) | No (n=338) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age (yr) | 67.92±13.49 | 66.34±11.03 | 0.280 |
1.01 (0.96–1.07) | 0.614 | - | - |
Sex | |||||||
Male | 3 (23.1) | 79 (23.4) | >0.999 |
0.98 (0.26–3.66) | 0.980 | - | - |
Female | 10 (76.9) | 259 (76.6) | - | - | |||
Diabetes mellitus | |||||||
Yes | 2 (15.4) | 66 (19.5) | >0.999 |
0.75 (0.16–3.46) | 0.712 | - | - |
No | 11 (84.6) | 272 (80.5) | 1.00 | - | - | ||
Hypertension | |||||||
Yes | 11 (84.6) | 182 (53.8) | 0.029 |
4.71 (1.03–21.59) | 0.046 | - | - |
No | 2 (15.4) | 156 (46.2) | 1.00 | - | - | ||
CKD | |||||||
Yes | 9 (69.2) | 57 (16.9) | <0.001 |
11.09 (3.30–37.26) | <0.001 | - | - |
No | 4 (30.8) | 281 (83.1) | 1.00 | - | - | ||
ACEi | |||||||
Yes | 4 (30.8) | 110 (32.5) | >0.999 |
0.88 (0.27–2.94) | 0.842 | - | - |
No | 9 (69.2) | 219 (64.8) | 1.00 | - | - | ||
NSAIDs | |||||||
Yes | 2 (15.4) | 50 (14.8) | >0.999 |
1.01 (0.22–4.72) | 0.985 | - | - |
No | 11 (84.6) | 279 (82.5) | 1.00 | - | - | ||
Anesthesia | |||||||
Spinal | 11 (84.6) | 267 (79.0) | >0.999 |
1.46 (0.32–6.75) | 0.626 | - | - |
General | 2 (15.4) | 71 (21.0) | 1.00 | - | - | ||
During operative bleeing (mL) | 155.77±149.41 | 227.57±260.51 | 0.558 |
1.00 (1.00–1.00) | 0.325 | - | - |
Operation time (min) | 173.08±25.78 | 186.88±41.10 | 0.267 |
0.99 (0.97–1.01) | 0.231 | - | - |
Type of surgery | |||||||
Total knee replacement | 9 (69.2) | 229 (67.8) | 1.000 |
1.07 (0.32–3.55) | 0.911 | - | - |
Total hip replacement | 4 (30.8) | 109 (32.2) | 1.00 | - | - | ||
Preoperative GFR (mL/min/1.73 m2) | 66.66±34.02 | 78.07±21.23 | 0.043 |
0.97 (0.95–1.00) | 0.058 | - | - |
ΔeGFR | –29.47±18.10 | 10.89±14.93 | <0.001 |
0.82 (0.75–0.90) | <0.001 | 0.74 (0.61–0.89) | 0.002 |
Albumin (g/dL) | 3.31±0.32 | 3.67±0.42 | 0.001 |
0.13 (0.03–0.49) | 0.003 | - | - |
Hemoglobin (g/dL) | 11.21±1.65 | 12.39±1.52 | 0.015 |
0.61 (0.43–0.88) | 0.008 | 0.13 (0.02–0.68) | 0.016 |
Postopeative CRP (mg/L) | 13.73±8.09 | 13.39±7.18 | 0.786 |
1.01 (0.93–1.09) | 0.870 | - | - |
Total CO2 (mmol/L) | 24.28±2.82 | 26.53±3.22 | 0.019 |
0.78 (0.64–0.95) | 0.013 | - | - |
Ejection fraction (%) | 65.04±6.99 | 64.66±4.09 | 0.354 |
1.02 (0.87–1.19) | 0.788 | - | - |
Hospital stay (day) | 24.82±6.59 | 23.55±12.14 | 0.104 |
1.01 (0.96–1.06) | 0.731 | - | - |
No. of prescribed drug | 7.36±3.93 | 4.11±3.47 | 0.006 |
1.23 (1.07–1.43) | 0.005 | - | - |
proBNP (ng/L) | 248.57±274.08 | 235.01±409.40 | 0.511 |
1.00 (1.00–1.00) | 0.954 | - | - |
Fluid therapy | |||||||
Crystalloid | 8 (61.5) | 211 (62.4) | 1.000 |
1.00 | - | - | |
Colloid | 5 (38.5) | 127 (37.6) | 1.04 (0.33–3.24) | 0.948 | - | - | |
Perioperative amount of fluid (mL) | 1,330.77±606.06 | 1,539.85±942.03 | 0.479 |
1.00 (1.00–1.00) | 0.425 | - | - |
Variable | Cut-point value of ΔeGFR | |
---|---|---|
≤–7.54 | >–7.54 | |
Acute kidney injury | ||
Yes | 13 | 0 |
No | 35 | 303 |
AUC (p-value) | 0.98 (<0.001) | |
Sensitivity (%) | 13/13 (100) | |
Specificity (%) | 303/338 (89.64) | |
FNR, 100%–sensitivity | 0/13 (0) | |
FPR, 100%–specificity | 35/338 (10.36) | |
PPV (%) | 13/48 (27.08) | |
NPV (%) | 303/303 (100) |
Values are presented as mean±standard deviation or number (%). CKD, chronic kidney disease; ACEi, angiotensin-converting enzyme inhibitor; NSAIDs, nonsteroidal anti-inflammatory drugs; eGFR, estimated glomerular filtration rate; ΔeGFR, change in eGFR at postoperative from baseline; CRP, C-reactive protein; proBPN, pro-B-type natriuretic peptide. In a multivariate logistic regression, the statistically significant variables in the univariate analyses were included. Then, categorical variables that have less frequency in a certain subgroup such as hypertension and CKD were excluded since the estimated odds ratio goes infinity and is not estimable. Finally, the statistically significant variables were selected in a backward elimination method with 0.05 alpha level. The
ΔeGFR, change in estimated glomerular filtration rate at postoperative from baseline; AUC, area under the curve; sensitivity, proportion of patients with acute kidney injury who had a lower than –7.54 for ΔeGFR; specificity, proportion of patients without acute kidney injury who had a higher than –7.54 for ΔeGFR; FNR, false-negative rate; FPR, false-positive rate; PPV, positive predicted value; NPV, negative predicted value. Concordance between ΔeGFR with –7.54 and acute kidney injury was good (316/351, 90.03%).